AUL
RVMD icon

AlphaGrep UK Ltd’s Revolution Medicines RVMD Stock Holding History

AlphaGrep UK Ltd’s Portfolio RVMD Stock Details RVMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$276K Buy
+2,836
New +$286K 0.08% 556

Other funds holding RVMD

FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

AlphaGrep UK Ltd's RVMD Position: Q1 2026 in Review

AlphaGrep UK Ltd opened a new position in Revolution Medicines (RVMD) in Q1 2026: 2,836 shares worth $276K. The stake represents 0.08% of the portfolio and ranks #556 among its holdings.

513 funds tracked by Wall St. Rank hold RVMD as of Q1 2026.

  • AlphaGrep UK Ltd held 2,836 shares of Revolution Medicines worth $276K as of Q1 2026.
  • Revolution Medicines was a new AlphaGrep UK Ltd position in Q1 2026.
  • Revolution Medicines made up 0.08% of AlphaGrep UK Ltd's portfolio in Q1 2026, its #556 holding.
  • 513 funds tracked by Wall St. Rank held Revolution Medicines as of Q1 2026.

Based on AlphaGrep UK Ltd's 13F filing for Q1 2026, filed 13 Aug 2026.